Foghorn Therapeutics Inc (FHTX)
4.80
+0.21
(+4.58%)
USD |
NASDAQ |
Jan 03, 16:00
4.76
-0.04
(-0.83%)
After-Hours: 20:00
Foghorn Therapeutics Profit Margin (Quarterly): -244.9% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| PureTech Health PLC | -- |
| Sana Biotechnology Inc | -- |
| Edgewise Therapeutics Inc | -- |
| Omega Therapeutics Inc | -629.6% |
| Moderna Inc | 0.70% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -30.59% |
| Operating Margin (Quarterly) | -305.5% |
| Return on Net Operating Assets | -228.5% |